| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF549 ZBTB41 BPTF SOHLH2 ZNF770 ZNF649 USP3 ZFP62 CUX2 CPHXL2 ZNF780B ZNF280C MED1 APP PRDM5 CLOCK ZIC1 ZNF182 ZNF526 ZNF605 EGR2 ZNF341 FEZF1 ZNF382 ZNF66 ZNF350 ZNF528 PRDM16 PRDM15 | 1.54e-05 | 1244 | 198 | 29 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF549 ZBTB41 BPTF SOHLH2 ZNF770 ZNF649 USP3 ZFP62 CUX2 CPHXL2 ZNF780B ZNF280C MED1 APP PRDM5 CLOCK ZIC1 ZNF182 ZNF526 ZNF605 EGR2 ZNF341 FEZF1 ZNF382 ZNF66 ZNF350 ZNF528 PRDM16 PRDM15 | 2.29e-05 | 1271 | 198 | 29 | GO:0000987 |
| GeneOntologyMolecularFunction | glycylpeptide N-tetradecanoyltransferase activity | 9.78e-05 | 2 | 198 | 2 | GO:0004379 | |
| GeneOntologyMolecularFunction | peptidyl-lysine N6-myristoyltransferase activity | 9.78e-05 | 2 | 198 | 2 | GO:0018030 | |
| GeneOntologyMolecularFunction | calmodulin binding | SPTAN1 ASPM KCNN1 PLCB3 CEP97 CAMK2A CAMK2B CAMK2D CAMK2G PCNT | 1.04e-04 | 230 | 198 | 10 | GO:0005516 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF549 ZBTB41 BPTF SOHLH2 ZNF770 ZNF649 USP3 ZFP62 CUX2 CPHXL2 ZNF780B ZNF280C MED1 APP PRDM5 CLOCK ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF66 ZNF350 ZNF528 PRDM16 PRDM15 | 1.10e-04 | 1459 | 198 | 30 | GO:0000977 |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 1.38e-04 | 27 | 198 | 4 | GO:0004683 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.92e-04 | 3 | 198 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 5.39e-04 | 102 | 198 | 6 | GO:0016410 | |
| GeneOntologyMolecularFunction | vitamin E binding | 5.79e-04 | 4 | 198 | 2 | GO:0008431 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 7.02e-04 | 18 | 198 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.02e-04 | 18 | 198 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 9.59e-04 | 5 | 198 | 2 | GO:0038177 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 3.78e-06 | 44 | 198 | 6 | GO:0060236 | |
| GeneOntologyBiologicalProcess | regulation of spindle organization | 6.36e-06 | 48 | 198 | 6 | GO:0090224 | |
| GeneOntologyBiologicalProcess | spindle organization | MAP9 ASPM HSPA1A HSPA1B CEP97 CHMP1B PARP3 MAPRE3 ARHGEF10 PDE4DIP PCNT | 1.14e-05 | 224 | 198 | 11 | GO:0007051 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | KNTC1 MAP9 CENPX RRP7BP CAVIN4 ASPM HSPA1A HSPA1B CEP97 CHMP1B NOA1 CCDC57 MAPRE3 ARHGEF10 CEP295 CEP152 | 1.50e-05 | 475 | 198 | 16 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MAP9 SPTAN1 FRMD7 MID1 HSPA1A HSPA1B CEP97 ALOX15 CHMP1B PARP3 CAPZA1 ARFGEF1 MAPRE3 ARHGEF10 PDE4DIP CEP295 CGNL1 | 4.62e-05 | 579 | 198 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 4.71e-05 | 8 | 198 | 3 | GO:0090063 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 5.27e-05 | 176 | 198 | 9 | GO:0070507 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle assembly | 7.53e-05 | 24 | 198 | 4 | GO:1901673 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-glycine N-myristoylation | 9.17e-05 | 2 | 198 | 2 | GO:0018008 | |
| GeneOntologyBiologicalProcess | organelle assembly | SNF8 KNTC1 MAP9 CENPX RRP7BP SPEF2 LRRK2 CAVIN4 ASPM HSPA1A HSPA1B CEP97 CHMP1B NOA1 LRRC4B CCDC57 DNAH7 MAPRE3 ARHGEF10 SEC23IP CFAP74 CEP295 CEP152 MPHOSPH9 PCNT | 9.68e-05 | 1138 | 198 | 25 | GO:0070925 |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 1.08e-04 | 151 | 198 | 8 | GO:0007052 | |
| GeneOntologyBiologicalProcess | spindle assembly | 1.18e-04 | 153 | 198 | 8 | GO:0051225 | |
| GeneOntologyBiologicalProcess | positive regulation of G2/M transition of mitotic cell cycle | 1.86e-04 | 30 | 198 | 4 | GO:0010971 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP9 SPEF2 MID1 ASPM HSPA1A HSPA1B CEP97 CHMP1B PARP3 CCDC57 DNAH7 MAPRE3 ARHGEF10 PDE4DIP CFAP74 CEP295 CEP152 PCNT | 2.10e-04 | 720 | 198 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP9 SPEF2 LYST DNAH14 MID1 ASPM HSPA1A HSPA1B DNAH6 CEP97 CHMP1B PARP3 KIF16B APP CCDC57 DNAH7 MAPRE3 ARHGEF10 PDE4DIP CFAP74 CEP295 CEP152 PCNT | 2.18e-04 | 1058 | 198 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | KNTC1 SPTAN1 FRMD7 LRRK2 MID1 PINX1 HSPA1A CEP97 EXOSC10 CAPZA1 ARFGEF1 MPHOSPH9 CGNL1 | 2.26e-04 | 421 | 198 | 13 | GO:0010639 |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 2.61e-04 | 92 | 198 | 6 | GO:0090307 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G2/M phase transition | 2.71e-04 | 33 | 198 | 4 | GO:1902751 | |
| GeneOntologyBiologicalProcess | peptidyl-glycine modification | 2.73e-04 | 3 | 198 | 2 | GO:0018201 | |
| GeneOntologyBiologicalProcess | cell cycle process | KNTC1 MAP9 CENPX MTA3 ASPM PINX1 HSPA1A HSPA1B CEP97 CHMP1B CAMK2A CAMK2B CAMK2D CAMK2G PARP3 MED1 APP CCDC57 CLOCK MAPRE3 ARHGEF10 PDE4DIP SEPTIN11 SMARCE1 CEP295 CEP152 CDC25B PCNT | 2.85e-04 | 1441 | 198 | 28 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 3.05e-04 | 34 | 198 | 4 | GO:0090169 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | KNTC1 MAP9 NEK3 MTA3 BTG3 PINX1 HSPA1A HSPA1B CEP97 CHMP1B CAMK2A CAMK2B CAMK2D CAMK2G PARP3 APP PRDM5 CCDC57 ARHGEF10 SMARCE1 CDC25B PCNT | 3.09e-04 | 1014 | 198 | 22 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTAN1 FRMD7 MID1 HSPA1A HSPA1B ALOX15 CAPZA1 ARFGEF1 APP MAPRE3 ARHGEF10 PDE4DIP CGNL1 | 3.31e-04 | 438 | 198 | 13 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 3.71e-04 | 181 | 198 | 8 | GO:0008277 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 4.04e-08 | 5 | 200 | 4 | GO:0005954 | |
| GeneOntologyCellularComponent | centrosome | DIS3L LRRC49 CCDC112 MID1 ASPM HSPA1A HSPA1B CEP97 CAMK2B PARP3 CCDC57 PPP4R3B ARHGEF10 CEP112 PDE4DIP ERCC6L2 CEP295 CEP152 MPHOSPH9 CDC25B ANKRD7 PCNT | 4.96e-06 | 770 | 200 | 22 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule | KNTC1 MAP9 LRRC49 ZNF804A DNAH14 MID1 ASPM BCL10 DNAH6 CHMP1B KIF16B CCDC57 DNAH7 MAPRE3 PDE4DIP CEP295 PCNT | 1.57e-05 | 533 | 200 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | microtubule organizing center | DIS3L LRRC49 CCDC112 MID1 ASPM HSPA1A HSPA1B CEP97 CAMK2B PARP3 CCDC57 PPP4R3B MAPRE3 ARHGEF10 CEP112 PDE4DIP ERCC6L2 CEP295 CEP152 MPHOSPH9 CDC25B ANKRD7 PCNT | 2.52e-05 | 919 | 200 | 23 | GO:0005815 |
| GeneOntologyCellularComponent | multivesicular body lumen | 2.94e-05 | 7 | 200 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | centriole | HSPA1A HSPA1B CEP97 PARP3 CCDC57 CEP295 CEP152 MPHOSPH9 PCNT | 4.30e-05 | 172 | 200 | 9 | GO:0005814 |
| GeneOntologyCellularComponent | late endosome lumen | 1.35e-04 | 11 | 200 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | spindle microtubule | 1.77e-04 | 86 | 200 | 6 | GO:0005876 | |
| GeneOntologyCellularComponent | spindle | KNTC1 MAP9 MID1 ASPM PINX1 CHMP1B CAMK2B KIF16B APP CCDC57 MBIP MAPRE3 CEP295 CDC25B | 1.87e-04 | 471 | 200 | 14 | GO:0005819 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.23e-04 | 96 | 200 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | cytoplasmic exosome (RNase complex) | 4.41e-04 | 16 | 200 | 3 | GO:0000177 | |
| GeneOntologyCellularComponent | spindle midzone | 5.67e-04 | 40 | 200 | 4 | GO:0051233 | |
| GeneOntologyCellularComponent | endosome lumen | 7.49e-04 | 43 | 200 | 4 | GO:0031904 | |
| GeneOntologyCellularComponent | postsynapse | ATP7A SPTAN1 LRRK2 RPS13 ADGRB3 LRRTM3 ZZEF1 ZNF804A ELFN2 PLCB3 DRP2 HTR7 CAMK2A CAMK2B CAMK2D CAMK2G LRRC4B APP OPHN1 SEPTIN11 SAMD14 | 7.84e-04 | 1018 | 200 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | exosome (RNase complex) | 1.51e-03 | 24 | 200 | 3 | GO:0000178 | |
| GeneOntologyCellularComponent | ATPase complex | 1.53e-03 | 129 | 200 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | multivesicular body | 1.57e-03 | 88 | 200 | 5 | GO:0005771 | |
| Domain | CaMKII_AD | 1.04e-08 | 4 | 190 | 4 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.04e-08 | 4 | 190 | 4 | IPR013543 | |
| Domain | Znf_C2H2 | ZNF549 ZBTB41 GPATCH8 ZNF804A ZNF638 ZNF770 ZNF649 ZFP62 ZNF780B ZNF280C ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 GTF2H2 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 1.87e-07 | 805 | 190 | 26 | IPR007087 |
| Domain | Znf_C2H2-like | ZNF549 ZBTB41 GPATCH8 ZNF804A ZNF638 ZNF770 ZNF649 ZFP62 ZNF780B ZNF280C ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 5.52e-07 | 796 | 190 | 25 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF549 ZBTB41 GPATCH8 ZNF804A ZNF638 ZNF770 ZNF649 ZFP62 ZNF780B ZNF280C ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 7.26e-07 | 808 | 190 | 25 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF549 ZBTB41 GPATCH8 ZNF804A ZNF770 ZNF649 ZFP62 ZNF780B ZNF280C ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 1.22e-06 | 775 | 190 | 24 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF549 ZBTB41 GPATCH8 ZNF804A ZNF770 ZNF649 ZFP62 ZNF780B ZNF280C ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 1.27e-06 | 777 | 190 | 24 | PS00028 |
| Domain | zf-C2H2_6 | ZNF549 ZBTB41 ZNF770 ZNF649 ZFP62 ZNF780B PRDM5 ZNF182 ZNF526 ZNF605 ZNF684 FEZF1 ZNF382 PRDM16 | 4.26e-06 | 314 | 190 | 14 | PF13912 |
| Domain | - | ZNF549 ZBTB41 ZNF770 ZNF649 ZFP62 ZNF780B ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 6.06e-06 | 679 | 190 | 21 | 3.30.160.60 |
| Domain | - | 6.91e-06 | 13 | 190 | 4 | 3.10.450.50 | |
| Domain | zf-C2H2 | ZNF549 ZBTB41 ZNF770 ZNF649 ZFP62 ZNF780B ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 8.27e-06 | 693 | 190 | 21 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF549 ZBTB41 ZNF770 ZNF649 ZFP62 ZNF780B ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 8.45e-06 | 694 | 190 | 21 | IPR013087 |
| Domain | NTF2-like_dom | 1.30e-05 | 15 | 190 | 4 | IPR032710 | |
| Domain | Aspartic_peptidase_N | 3.52e-05 | 7 | 190 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 3.52e-05 | 7 | 190 | 3 | PF07966 | |
| Domain | Znf_C2H2_jaz | 6.58e-05 | 22 | 190 | 4 | IPR022755 | |
| Domain | zf-C2H2_jaz | 6.58e-05 | 22 | 190 | 4 | PF12171 | |
| Domain | NMT_1 | 1.03e-04 | 2 | 190 | 2 | PS00975 | |
| Domain | NMT_2 | 1.03e-04 | 2 | 190 | 2 | PS00976 | |
| Domain | NMT_C | 1.03e-04 | 2 | 190 | 2 | PF02799 | |
| Domain | NMT | 1.03e-04 | 2 | 190 | 2 | PF01233 | |
| Domain | Rrp44_S1 | 1.03e-04 | 2 | 190 | 2 | PF17215 | |
| Domain | MyristoylCoA_TrFase_C | 1.03e-04 | 2 | 190 | 2 | IPR022677 | |
| Domain | MyristoylCoA_TrFase_N | 1.03e-04 | 2 | 190 | 2 | IPR022676 | |
| Domain | MyristoylCoA_TrFase_CS | 1.03e-04 | 2 | 190 | 2 | IPR022678 | |
| Domain | RRP44_S1 | 1.03e-04 | 2 | 190 | 2 | IPR033770 | |
| Domain | MyristoylCoA_TrFase | 1.03e-04 | 2 | 190 | 2 | IPR000903 | |
| Domain | Aspartic_peptidase_A1 | 1.18e-04 | 10 | 190 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 1.18e-04 | 10 | 190 | 3 | IPR033121 | |
| Domain | Asp | 1.18e-04 | 10 | 190 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 1.18e-04 | 10 | 190 | 3 | PS51767 | |
| Domain | - | 2.13e-04 | 12 | 190 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 2.13e-04 | 12 | 190 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 2.75e-04 | 13 | 190 | 3 | IPR001969 | |
| Domain | RIBONUCLEASE_II | 3.07e-04 | 3 | 190 | 2 | PS01175 | |
| Domain | Rrp44_CSD1 | 3.07e-04 | 3 | 190 | 2 | PF17216 | |
| Domain | Rrp44_CSD1 | 3.07e-04 | 3 | 190 | 2 | IPR033771 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.47e-04 | 14 | 190 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.47e-04 | 14 | 190 | 3 | IPR024743 | |
| Domain | MT | 3.47e-04 | 14 | 190 | 3 | PF12777 | |
| Domain | AAA_8 | 3.47e-04 | 14 | 190 | 3 | PF12780 | |
| Domain | DHC_fam | 4.31e-04 | 15 | 190 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 4.31e-04 | 15 | 190 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.31e-04 | 15 | 190 | 3 | IPR004273 | |
| Domain | RNase_II/R_CS | 6.09e-04 | 4 | 190 | 2 | IPR022966 | |
| Domain | DDT | 6.09e-04 | 4 | 190 | 2 | PF02791 | |
| Domain | Peptidase_aspartic_dom | 6.34e-04 | 17 | 190 | 3 | IPR021109 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 6.86e-04 | 69 | 190 | 5 | IPR020636 | |
| Domain | DDT | 1.01e-03 | 5 | 190 | 2 | SM00571 | |
| Domain | HRDC-like | 1.01e-03 | 5 | 190 | 2 | IPR010997 | |
| Domain | DDT_dom | 1.01e-03 | 5 | 190 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 1.01e-03 | 5 | 190 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 1.01e-03 | 5 | 190 | 2 | IPR028941 | |
| Domain | WSD | 1.01e-03 | 5 | 190 | 2 | PF15613 | |
| Domain | WHIM1 | 1.01e-03 | 5 | 190 | 2 | PF15612 | |
| Domain | DDT | 1.50e-03 | 6 | 190 | 2 | PS50827 | |
| Domain | TRP_2 | 1.50e-03 | 6 | 190 | 2 | PF08344 | |
| Domain | TRP_dom | 1.50e-03 | 6 | 190 | 2 | IPR013555 | |
| Domain | TRPC_channel | 2.09e-03 | 7 | 190 | 2 | IPR002153 | |
| Domain | Bromodomain_CS | 2.27e-03 | 26 | 190 | 3 | IPR018359 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 6.37e-08 | 23 | 136 | 6 | MM14953 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.55e-06 | 38 | 136 | 6 | M27255 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.66e-06 | 10 | 136 | 4 | M26910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.38e-06 | 28 | 136 | 5 | M47508 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 7.70e-06 | 14 | 136 | 4 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 7.70e-06 | 14 | 136 | 4 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.04e-05 | 15 | 136 | 4 | M47385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.79e-05 | 17 | 136 | 4 | M47387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 2.87e-05 | 19 | 136 | 4 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.87e-05 | 19 | 136 | 4 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 3.56e-05 | 20 | 136 | 4 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.37e-05 | 21 | 136 | 4 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 4.37e-05 | 21 | 136 | 4 | M27944 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.17e-05 | 176 | 136 | 9 | MM15718 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 5.30e-05 | 22 | 136 | 4 | MM15104 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.36e-05 | 23 | 136 | 4 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 6.36e-05 | 23 | 136 | 4 | M27949 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.99e-05 | 183 | 136 | 9 | M997 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.58e-05 | 24 | 136 | 4 | M47509 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 8.42e-05 | 75 | 136 | 6 | M39568 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 8.60e-05 | 47 | 136 | 5 | M39531 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.96e-05 | 25 | 136 | 4 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.96e-05 | 25 | 136 | 4 | M47511 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 1.37e-04 | 11 | 136 | 3 | M39726 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.42e-04 | 28 | 136 | 4 | M837 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.63e-04 | 29 | 136 | 4 | MM15028 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.68e-04 | 54 | 136 | 5 | M26911 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.68e-04 | 54 | 136 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.68e-04 | 54 | 136 | 5 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.83e-04 | 55 | 136 | 5 | M971 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.87e-04 | 30 | 136 | 4 | M27566 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.13e-04 | 31 | 136 | 4 | M7223 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.17e-04 | 57 | 136 | 5 | MM15643 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.42e-04 | 32 | 136 | 4 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 2.42e-04 | 32 | 136 | 4 | M27900 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.61e-04 | 92 | 136 | 6 | MM14951 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.73e-04 | 33 | 136 | 4 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.07e-04 | 34 | 136 | 4 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.44e-04 | 35 | 136 | 4 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.44e-04 | 35 | 136 | 4 | MM15109 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 3.78e-04 | 138 | 136 | 7 | MM15635 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 4.28e-04 | 37 | 136 | 4 | M749 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.32e-04 | 101 | 136 | 6 | M27253 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 5.68e-04 | 70 | 136 | 5 | M3115 | |
| Pathway | PID_IFNG_PATHWAY | 5.79e-04 | 40 | 136 | 4 | M161 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 6.36e-04 | 41 | 136 | 4 | M512 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 7.84e-04 | 113 | 136 | 6 | M39669 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 8.34e-04 | 44 | 136 | 4 | M39845 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 8.34e-04 | 44 | 136 | 4 | M27934 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 9.09e-04 | 45 | 136 | 4 | M27623 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.29e-03 | 272 | 136 | 9 | M29619 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.69e-03 | 178 | 136 | 7 | M2890 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.77e-03 | 90 | 136 | 5 | M6467 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 1.10e-09 | 4 | 202 | 4 | 17367784 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 11889801 | ||
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 11013247 | ||
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 21209221 | ||
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 14722083 | ||
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 18218981 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 5.50e-09 | 5 | 202 | 4 | 16436603 | |
| Pubmed | KNTC1 MAP9 DENND4A SPEF2 SPTAN1 ZBTB41 LYST BPTF WDR75 ASPM USP1 CCDC89 DNAH6 ELOA CUX2 CAMK2B CAMK2G CAPZA1 CCDC57 AAR2 GUCY1A2 BAZ1A CEP112 SEC23IP ANKRD30A CFAP74 CEP295 ZNF350 PCNT | 6.02e-09 | 1442 | 202 | 29 | 35575683 | |
| Pubmed | AKAP17A DIS3L SPTAN1 ADGRB3 DNAJB9 MTA3 TCERG1 NMT2 ARID5B KCNN1 BTG3 HSPA1A HSPA1B BRWD1 CAMK2A LAMB1 APP PPP4R3B RNF123 ZNF605 ARHGEF10 PDE4DIP SEC23IP SMARCE1 ZNF350 ZNF528 PCNT | 8.57e-09 | 1285 | 202 | 27 | 35914814 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 1.64e-08 | 6 | 202 | 4 | 18948074 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KNTC1 SPTAN1 RPS13 ADGRB3 ZNF804A RBM25 TCERG1 PIPSL HSPA1A HSPA1B DNAH6 BRWD1 EXOSC10 CAMK2D CAMK2G PARP3 CAPZA1 RBM28 PPP4R3B SEPTIN11 PCNT | 2.81e-08 | 847 | 202 | 21 | 35235311 |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 3.81e-08 | 7 | 202 | 4 | 9115241 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CENPX RPS13 GPATCH8 ARHGAP11A TTF1 BPTF RBM25 WDR75 TCERG1 C16orf87 ARID5B ZNF638 NKTR HSPA1B USP3 DEK EXOSC10 ING3 RBM28 MED1 CPT1A CLOCK MBIP BAZ1A ANKRD11 SMARCE1 | 4.05e-08 | 1294 | 202 | 26 | 30804502 |
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 11264466 | ||
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 20668654 | ||
| Pubmed | RALGAPA1 ADGRB3 ARHGAP11A ZZEF1 TRANK1 MTA3 JOSD1 OXSR1 CRAMP1 ZNF280C KIF16B CLOCK DIS3 PPP4R3B AFAP1 RBM12 | 9.76e-08 | 529 | 202 | 16 | 14621295 | |
| Pubmed | 1.36e-07 | 9 | 202 | 4 | 12660151 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 7926498 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 9561228 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 21455714 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 19800305 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 1.93e-07 | 3 | 202 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 1.93e-07 | 3 | 202 | 3 | 2799289 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 1.93e-07 | 3 | 202 | 3 | 1968039 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 1.93e-07 | 3 | 202 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 1.93e-07 | 3 | 202 | 3 | 2229438 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 1.93e-07 | 3 | 202 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 1.93e-07 | 3 | 202 | 3 | 8244094 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 21407214 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 6774973 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 1.93e-07 | 3 | 202 | 3 | 22304859 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 24004680 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 1.93e-07 | 3 | 202 | 3 | 2227273 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 9882483 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 23034090 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 24125879 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 1.93e-07 | 3 | 202 | 3 | 3554488 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 23521833 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 1.93e-07 | 3 | 202 | 3 | 21989121 | |
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 1.93e-07 | 3 | 202 | 3 | 9060999 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 10819240 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 9855083 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 9797498 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 2478370 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 1.93e-07 | 3 | 202 | 3 | 10675278 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 3780036 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 1.93e-07 | 3 | 202 | 3 | 3839486 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 20844140 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 3467902 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 1.93e-07 | 3 | 202 | 3 | 2892778 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 24383519 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 1.93e-07 | 3 | 202 | 3 | 2831884 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 2032552 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 11325525 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 1812762 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 7923573 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 1.93e-07 | 3 | 202 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 1.93e-07 | 3 | 202 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 1.93e-07 | 3 | 202 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 1.93e-07 | 3 | 202 | 3 | 1956484 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 8540382 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 1.93e-07 | 3 | 202 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 1.93e-07 | 3 | 202 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 1.93e-07 | 3 | 202 | 3 | 21970995 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 20428942 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 9525001 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 7886402 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 17379991 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 21547904 | ||
| Pubmed | 2.26e-07 | 10 | 202 | 4 | 19776387 | ||
| Pubmed | 2.26e-07 | 10 | 202 | 4 | 28361052 | ||
| Pubmed | MAP9 ZBTB41 GPATCH8 WDR75 ARID5B ZNF638 NMT1 USP3 STK24 BRWD1 EXOSC10 SOST CAMK2D RBM28 DIS3 ZNF182 ZNF341 BAZ1A CEP112 SEPTIN11 CEP295 PCNT | 4.10e-07 | 1084 | 202 | 22 | 11544199 | |
| Pubmed | 5.27e-07 | 12 | 202 | 4 | 8615909 | ||
| Pubmed | 5.27e-07 | 12 | 202 | 4 | 8665664 | ||
| Pubmed | 5.27e-07 | 12 | 202 | 4 | 12815021 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GSE1 TCERG1 ZNF638 PRMT7 NMT1 HSPA1A PUS7 EHBP1 ELOA EXOSC10 ZNF280C CAPZA1 MED1 DIS3 RBM12 BAZ1A SEC23IP SMARCE1 CGNL1 PCNT | 6.24e-07 | 934 | 202 | 20 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GPATCH8 ARHGAP11A BPTF MTA3 PINX1 ZNF770 ZNF649 USP3 DEK BRWD1 ELOA ZNF280C MED1 BAZ1A SMARCE1 PRDM15 | 6.25e-07 | 608 | 202 | 16 | 36089195 |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 7.69e-07 | 4 | 202 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 7.69e-07 | 4 | 202 | 3 | 11915945 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 7.69e-07 | 4 | 202 | 3 | 17136346 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 12698190 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 DENND4A SPTAN1 LYST TMCC3 TCERG1 EHBP1 DSC2 CAMK2A CAMK2D DNAH7 ARHGEF10 CEP112 ANKRD11 CEP152 MPHOSPH9 CGNL1 CDC25B TSSK1B | 7.75e-07 | 861 | 202 | 19 | 36931259 |
| Pubmed | 1.06e-06 | 14 | 202 | 4 | 32060285 | ||
| Pubmed | 1.06e-06 | 14 | 202 | 4 | 10373510 | ||
| Interaction | NINL interactions | AKAP17A CCDC112 TRPM5 GSE1 UBR5 HSPA1B CEP97 ELOA CAMK2A CAMK2B CAMK2D CAMK2G CAPZA1 CCDC57 MBIP CEP295 CEP152 MPHOSPH9 CGNL1 PCNT | 2.38e-08 | 458 | 196 | 20 | int:NINL |
| Interaction | DNAH14 interactions | 3.09e-07 | 29 | 196 | 6 | int:DNAH14 | |
| Interaction | CALM3 interactions | DENND4A SPTAN1 LRRK2 ELFN2 ASPM KCNN1 PINX1 PLCB3 CEP97 CAMK2A CAMK2B CAMK2D CAMK2G CAPZA1 PCNT | 1.42e-06 | 343 | 196 | 15 | int:CALM3 |
| Interaction | CAMK2N1 interactions | 1.74e-06 | 10 | 196 | 4 | int:CAMK2N1 | |
| Interaction | EXOSC3 interactions | 6.01e-06 | 100 | 196 | 8 | int:EXOSC3 | |
| Interaction | SFN interactions | RALGAPA1 DENND4A SPTAN1 LRRK2 RPS13 SAMSN1 ARHGAP11A LYST TMCC3 RBM25 ZNF638 OXSR1 DEK DSC2 COP1 ARHGEF10 CEP112 MPHOSPH9 CGNL1 CDC25B | 1.45e-05 | 692 | 196 | 20 | int:SFN |
| Interaction | PLK4 interactions | 2.04e-05 | 154 | 196 | 9 | int:PLK4 | |
| Interaction | CIBAR2 interactions | 3.08e-05 | 7 | 196 | 3 | int:CIBAR2 | |
| Interaction | CAMK2N2 interactions | 3.08e-05 | 7 | 196 | 3 | int:CAMK2N2 | |
| Interaction | C1orf87 interactions | 4.56e-05 | 21 | 196 | 4 | int:C1orf87 | |
| Interaction | DCTN2 interactions | RBM25 RIC8A HSPA1A EHBP1 CAMK2A CAPZA1 ARFGEF1 MAPRE3 ARHGEF10 CEP152 MPHOSPH9 TSSK1B PCNT | 4.84e-05 | 356 | 196 | 13 | int:DCTN2 |
| Interaction | CEP63 interactions | RALGAPA1 SPTAN1 LRRC49 GSE1 MBIP SMARCE1 CEP152 MPHOSPH9 PCNT | 6.63e-05 | 179 | 196 | 9 | int:CEP63 |
| Interaction | CEP135 interactions | LRRC49 GSE1 STK24 CEP97 CEP112 SEC23IP CEP295 CEP152 MPHOSPH9 CGNL1 PCNT | 7.56e-05 | 272 | 196 | 11 | int:CEP135 |
| Interaction | HDAC1 interactions | SPTAN1 LRRC49 SAMSN1 BPTF RBM25 GSE1 MTA3 UBR5 C16orf87 ARID5B ZNF638 HSPA1A HSPA1B STK24 EHBP1 CAMK2G ARFGEF1 PRDM5 MBIP RNF123 BAZ1A SEC23IP SMARCE1 PRDM16 PCNT | 7.74e-05 | 1108 | 196 | 25 | int:HDAC1 |
| Interaction | ACTR1A interactions | RBM25 UBR5 RIC8A HSPA1A DEK STK24 CAMK2B CAMK2D CAMK2G CAPZA1 PRDM16 | 8.07e-05 | 274 | 196 | 11 | int:ACTR1A |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF549 ZBTB41 ZNF770 ZNF649 ZFP62 ZNF780B ZNF407 PRDM5 ZIC1 ZNF182 ZNF526 ZNF605 ZNF684 EGR2 ZNF341 FEZF1 ZNF382 ZNF350 ZNF528 PRDM16 PRDM15 | 2.07e-08 | 718 | 125 | 21 | 28 |
| GeneFamily | Exosome complex | 6.78e-05 | 12 | 125 | 3 | 817 | |
| GeneFamily | Dyneins, axonemal | 2.04e-04 | 17 | 125 | 3 | 536 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.04e-04 | 17 | 125 | 3 | 1197 | |
| GeneFamily | Transient receptor potential cation channels | 9.31e-04 | 28 | 125 | 3 | 249 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRPC1 GPATCH8 ARHGAP11A ZZEF1 ZNF804A BPTF GSE1 UBR5 NMT2 MID1 ARID5B ZNF638 OXSR1 DEK STK24 EHBP1 ARFGEF1 MED1 APP CLOCK AFAP1 ARHGEF10 BAZ1A MPHOSPH9 PCNT | 1.01e-08 | 856 | 200 | 25 | M4500 |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | ZBTB41 WDR75 TCERG1 MID1 ZNF770 HSPA1A HSPA1B PUS7 COP1 ERCC6L2 | 3.27e-06 | 199 | 200 | 10 | M5607 |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 5.26e-06 | 165 | 200 | 9 | M8992 | |
| Coexpression | CRX_NRL_DN.V1_UP | 1.26e-05 | 140 | 200 | 8 | M2796 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 ARHGAP11A CCDC112 BPTF MID1 ASPM ZNF638 NKTR USP1 DEK OSTM1 KIF16B ARFGEF1 ZNF407 GTF2H2 BAZ1A CEP112 | 1.27e-05 | 656 | 200 | 17 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZNF804A BPTF UBR5 NMT2 MID1 ARID5B ZNF638 OXSR1 STK24 EHBP1 ARFGEF1 CLOCK AFAP1 BAZ1A | 1.52e-05 | 466 | 200 | 14 | M13522 |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 2.27e-05 | 198 | 200 | 9 | M8169 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN | ARHGAP11A SLC25A53 ATL2 BRWD1 CCDC57 CEP152 MPHOSPH9 SAMD14 LARGE1 | 2.46e-05 | 200 | 200 | 9 | M6196 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CCPG1 ATP7A TRPC1 LYST TMCC3 C16orf87 AMOTL1 ARID5B HSPA1A HSPA1B ING3 CHMP1B CAMK2D APP CLOCK PPP4R3B P3H2 PDE4DIP RASSF9 | 3.22e-05 | 854 | 200 | 19 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CCPG1 ATP7A TRPC1 LYST TMCC3 C16orf87 AMOTL1 ARID5B HSPA1A HSPA1B ING3 CHMP1B CAMK2D APP CLOCK PPP4R3B P3H2 PDE4DIP RASSF9 | 5.44e-05 | 888 | 200 | 19 | MM1018 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 6.69e-05 | 90 | 200 | 6 | M39250 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 DENND4A SPEF2 SPTAN1 RPS13 GPATCH8 SAMSN1 LYST BPTF TRANK1 UBR5 ZNF638 USP1 DEK STK24 BRWD1 OSTM1 HTR7 CAPZA1 MED1 PPP4R3B RBM12 BAZ1A PDE4DIP ANKRD11 SMARCE1 | 7.36e-05 | 1492 | 200 | 26 | M40023 |
| Coexpression | BENPORATH_NANOG_TARGETS | KNTC1 LRRC49 RPS13 ARHGAP11A TTF1 TCERG1 UBR5 AMOTL1 ARID5B JOSD1 ZNF770 NKTR NMT1 USP3 EHBP1 CPT1A ZIC1 GTF2H2 ZNF684 LARGE1 | 7.38e-05 | 988 | 200 | 20 | M6616 |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 7.91e-05 | 181 | 200 | 8 | M6849 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DIS3L ZZEF1 ZNF804A TMCC3 GSE1 MTA3 PINX1 USP1 DEK STK24 CEP97 APP DIS3 AFAP1 ARHGEF10 CEP112 RRAGA PDE4DIP MPHOSPH9 CGNL1 | 9.81e-05 | 1009 | 200 | 20 | M157 |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN | 1.33e-04 | 195 | 200 | 8 | M7263 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.53e-04 | 199 | 200 | 8 | M6264 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 1.53e-04 | 199 | 200 | 8 | M5486 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN | 1.53e-04 | 199 | 200 | 8 | M4407 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN | 1.58e-04 | 200 | 200 | 8 | M8558 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP | 1.58e-04 | 200 | 200 | 8 | M9776 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN | 1.58e-04 | 200 | 200 | 8 | M5096 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP | 1.58e-04 | 200 | 200 | 8 | M5613 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | DENND4A ADGRB3 ZZEF1 TTF1 BLVRA CCDC112 GSE1 CUX2 OSTM1 PARP3 ZNF780B CPT1A CCDC57 TRMU MAPRE3 RNF123 CEP112 PDE4DIP CDC25B SAMD14 PRDM16 | 3.53e-06 | 721 | 196 | 21 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | DIS3L ADGRB3 ACVR2B CCDC112 RBM25 TRPM5 GSE1 UBR5 MID1 ASPM NMT1 USP1 DEK OSTM1 EGFL6 ZIC1 POSTN MAPRE3 FEZF1 BAZ1A ANKRD11 CDC25B PRDM16 PCNT | 1.37e-05 | 983 | 196 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | DENND4A ADGRB3 ZZEF1 TTF1 BLVRA CCDC112 GSE1 CUX2 OSTM1 PARP3 ZNF780B CPT1A CCDC57 ZIC1 MAPRE3 RNF123 CEP112 PDE4DIP CDC25B PRDM16 | 1.49e-05 | 730 | 196 | 20 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | DENND4A ADGRB3 ZZEF1 TTF1 CCDC112 GSE1 CCDC89 CUX2 OSTM1 PARP3 ZNF780B CPT1A TRMU MAPRE3 RNF123 CEP112 PDE4DIP CDC25B SAMD14 PRDM16 | 2.07e-05 | 747 | 196 | 20 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SPTAN1 RBM25 TCERG1 UBR5 C16orf87 NMT2 ASPM ZNF638 PINX1 NMT1 USP1 GTF2H2 BAZ1A ANKRD11 MPHOSPH9 PCNT | 3.68e-05 | 532 | 196 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | TRPC1 SPTAN1 LRRK2 ZNF804A LYST AMOTL1 ARID5B PLCB3 HSPA1A HSPA1B CAMK2D PARP3 APP CLOCK POSTN AFAP1 GUCY1A2 CEP112 P3H2 SEPTIN11 RASSF9 | 5.97e-05 | 872 | 196 | 21 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | AKAP17A ACVR2B BPTF RBM25 MID1 NKTR DEK BAZ1A SEPTIN11 CEP295 | 1.30e-08 | 185 | 201 | 10 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.36e-08 | 197 | 201 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.34e-07 | 200 | 201 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.14e-06 | 171 | 201 | 8 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.31e-06 | 188 | 201 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-06 | 188 | 201 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-06 | 188 | 201 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-06 | 188 | 201 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-06 | 190 | 201 | 8 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.81e-06 | 193 | 201 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.81e-06 | 193 | 201 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-06 | 193 | 201 | 8 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.52e-06 | 199 | 201 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.34e-05 | 172 | 201 | 7 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-05 | 183 | 201 | 7 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-05 | 184 | 201 | 7 | 780d67f04fc795f614e077d8a5cf368542f6d99d | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 201 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 201 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-05 | 187 | 201 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-05 | 190 | 201 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.55e-05 | 190 | 201 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.63e-05 | 191 | 201 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.63e-05 | 191 | 201 | 7 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.72e-05 | 192 | 201 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-05 | 197 | 201 | 7 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 198 | 201 | 7 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.42e-05 | 199 | 201 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.53e-05 | 200 | 201 | 7 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 200 | 201 | 7 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 3.53e-05 | 200 | 201 | 7 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 3.53e-05 | 200 | 201 | 7 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.96e-05 | 149 | 201 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.68e-05 | 156 | 201 | 6 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.96e-05 | 157 | 201 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-05 | 157 | 201 | 6 | abfd05ed993b80822739f47a735f154092a23632 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.14e-05 | 161 | 201 | 6 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 170 | 201 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 172 | 201 | 6 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 172 | 201 | 6 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 175 | 201 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 176 | 201 | 6 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 176 | 201 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 179 | 201 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 181 | 201 | 6 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 181 | 201 | 6 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 181 | 201 | 6 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 181 | 201 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 181 | 201 | 6 | b9fe3833a6a56b9fbe5c257393fdbea5bf8ac4a3 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-04 | 182 | 201 | 6 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 182 | 201 | 6 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-04 | 183 | 201 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.84e-04 | 183 | 201 | 6 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 185 | 201 | 6 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-04 | 186 | 201 | 6 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 186 | 201 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 187 | 201 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 2.07e-04 | 187 | 201 | 6 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 188 | 201 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.13e-04 | 188 | 201 | 6 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 188 | 201 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 188 | 201 | 6 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.19e-04 | 189 | 201 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-04 | 190 | 201 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-04 | 190 | 201 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-04 | 190 | 201 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.25e-04 | 190 | 201 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-04 | 190 | 201 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.32e-04 | 191 | 201 | 6 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 2.32e-04 | 191 | 201 | 6 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 2.32e-04 | 191 | 201 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.32e-04 | 191 | 201 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.38e-04 | 192 | 201 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.38e-04 | 192 | 201 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.38e-04 | 192 | 201 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-04 | 192 | 201 | 6 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 192 | 201 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.38e-04 | 192 | 201 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.45e-04 | 193 | 201 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.45e-04 | 193 | 201 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-04 | 193 | 201 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.45e-04 | 193 | 201 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.45e-04 | 193 | 201 | 6 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.52e-04 | 194 | 201 | 6 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.52e-04 | 194 | 201 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-04 | 194 | 201 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | CV-Severe-6|Severe / Virus stimulation, Condition and Cluster | 2.52e-04 | 194 | 201 | 6 | d33be6ed1de907aeea0c2dce09796556b8efdd4e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-04 | 194 | 201 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-04 | 195 | 201 | 6 | 6a0460d949ccda7c9fe76870d3ee6c2f60677d61 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 195 | 201 | 6 | 5276e874615823bb00e20ff160692e0946d7d400 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.59e-04 | 195 | 201 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 196 | 201 | 6 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 196 | 201 | 6 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 196 | 201 | 6 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.74e-04 | 197 | 201 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.74e-04 | 197 | 201 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 197 | 201 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 2.74e-04 | 197 | 201 | 6 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 198 | 201 | 6 | 294a48ef6c0b89c7be948452cea79d23d3901e75 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-04 | 198 | 201 | 6 | c65103828a4755fcf3c0776c60d8ada1f0ad5278 | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.81e-04 | 198 | 201 | 6 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| Drug | Antigens, Polyomavirus Transforming | KNTC1 CENPX ARHGAP11A SLC25A25 TCERG1 ASPM NKTR ATL2 USP1 EXOSC10 ING3 ERO1B ARFGEF1 LAMB1 POSTN PDE4DIP ANKRD11 CEP152 MPHOSPH9 CDC25B | 1.67e-06 | 668 | 198 | 20 | ctd:D000952 |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.60e-06 | 177 | 198 | 10 | 985_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.98e-06 | 179 | 198 | 10 | 4585_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | TRPC1 SPTAN1 CEP97 ALOX15 DSC2 CAMK2B APP DIS3 ARHGEF10 PDE4DIP | 7.07e-06 | 191 | 198 | 10 | 994_UP |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | RALGAPA1 SPTAN1 NMT2 ATL2 DSC2 HTR7 DIS3 PPP4R3B AFAP1 SEPTIN11 | 8.11e-06 | 194 | 198 | 10 | 6729_DN |
| Drug | Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; PC3; HT_HG-U133A | DENND4A ZNF549 ARHGAP11A NYNRIN STK24 BRWD1 TCP11 CEP112 ZNF350 MPHOSPH9 | 1.01e-05 | 199 | 198 | 10 | 7249_UP |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | SPTAN1 NMT1 DSC2 PARP3 CPT1A DIS3 TRMU PPP4R3B PDE4DIP SEPTIN11 | 1.01e-05 | 199 | 198 | 10 | 4649_DN |
| Drug | AC1NRCNR | 1.94e-05 | 19 | 198 | 4 | CID005289096 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 5.26e-06 | 6 | 191 | 3 | DOID:9562 (is_implicated_in) | |
| Disease | bone structure disease (implicated_via_orthology) | 4.17e-05 | 2 | 191 | 2 | DOID:0080010 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 5.31e-05 | 32 | 191 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | ZNF804A TRANK1 CUX2 TRPC7 CHMP1B CAMK2A APP CLOCK ARHGEF10 EGR2 SEPTIN11 PCNT | 7.07e-05 | 477 | 191 | 12 | C0005586 |
| Disease | Seckel syndrome 1 | 1.25e-04 | 3 | 191 | 2 | C4551474 | |
| Disease | serum gamma-glutamyl transferase measurement | GALNT3 ZNF804A BPTF RBM25 TRANK1 GSE1 PINX1 JOSD1 USP3 EHBP1 CUX2 IQCH CAMK2G FAM227B SLCO1B7 CGNL1 | 3.19e-04 | 914 | 191 | 16 | EFO_0004532 |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 4.12e-04 | 5 | 191 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | muscular disease (implicated_via_orthology) | 4.12e-04 | 5 | 191 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 7.62e-04 | 229 | 191 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 7.66e-04 | 166 | 191 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | bipolar disorder (implicated_via_orthology) | 8.57e-04 | 7 | 191 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | chronic rhinosinusitis | 1.38e-03 | 34 | 191 | 3 | EFO_1000024 | |
| Disease | Todd Paralysis | 1.46e-03 | 9 | 191 | 2 | C0234544 | |
| Disease | Paralysed | 1.46e-03 | 9 | 191 | 2 | C0522224 | |
| Disease | Major depression, single episode | 1.46e-03 | 9 | 191 | 2 | C0024517 | |
| Disease | Parkinsonism (is_implicated_in) | 2.21e-03 | 11 | 191 | 2 | DOID:0080855 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 2.21e-03 | 11 | 191 | 2 | OBA_2045197 | |
| Disease | visual epilepsy (is_implicated_in) | 2.21e-03 | 11 | 191 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | rotator cuff tear, shoulder impingement syndrome | 2.64e-03 | 12 | 191 | 2 | EFO_1001178, EFO_1001250 | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.64e-03 | 12 | 191 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.65e-03 | 447 | 191 | 9 | C3714756 | |
| Disease | waist-hip ratio | KNTC1 ZZEF1 BPTF GSE1 ARID5B PLCB3 PIPSL USP3 STK24 CUX2 IQCH ARFGEF1 LAMB1 ZNF407 CLOCK RNF123 PRDM16 | 2.67e-03 | 1226 | 191 | 17 | EFO_0004343 |
| Disease | eye colour measurement | 3.05e-03 | 218 | 191 | 6 | EFO_0009764 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 3.10e-03 | 13 | 191 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.19e-03 | 220 | 191 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | body weight | RALGAPA1 KNTC1 ADGRB3 ZZEF1 DNAH14 BPTF QRFPR GSE1 ZNF638 PRMT7 EHBP1 CUX2 ZNF280C PRDM5 ZNF341 FEZF1 CEP112 | 3.55e-03 | 1261 | 191 | 17 | EFO_0004338 |
| Disease | age at first sexual intercourse measurement | 3.64e-03 | 383 | 191 | 8 | EFO_0009749 | |
| Disease | complement factor H-related protein 4 measurement | 3.95e-03 | 49 | 191 | 3 | EFO_0600091 | |
| Disease | gamma-glutamylphenylalanine measurement | 4.14e-03 | 15 | 191 | 2 | EFO_0021142 | |
| Disease | Autosomal recessive primary microcephaly | 4.14e-03 | 15 | 191 | 2 | cv:C3711387 | |
| Disease | suntan | 4.57e-03 | 103 | 191 | 4 | EFO_0004279 | |
| Disease | Moyamoya Disease | 5.32e-03 | 17 | 191 | 2 | C0026654 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.95e-03 | 111 | 191 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | systemic lupus erythematosus | ZNF804A LYST ARID5B PINX1 HSPA1A HSPA1B PUS7 TCP11 CAMK2G MED1 ARHGAP27 SEC14L2 | 6.07e-03 | 799 | 191 | 12 | MONDO_0007915 |
| Disease | Mental Depression | 6.38e-03 | 254 | 191 | 6 | C0011570 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRKKRKKDFQHLISS | 51 | Q15361 | |
| LNKKDKHLSLRIADT | 86 | A0A0B4J249 | |
| QKQRFEEKRFKLDHS | 196 | Q8NHY2 | |
| EVKQDFEKFLHKLRS | 461 | Q96M60 | |
| SNHKKQLSHDLTRLK | 301 | O15013 | |
| RHKADRLKSDFKKLS | 1661 | O94986 | |
| LVQRKALTSKLEHKD | 381 | Q8IUX8 | |
| LENKLIHSRKTERAK | 26 | Q8NEF3 | |
| FKKHSLDLLSKEREL | 351 | Q8N998 | |
| ENKLKVLKHDRDHFK | 681 | Q6UB99 | |
| FQKAKERLEAKHRER | 391 | P05067 | |
| DHFSHEKIKDLLRKN | 91 | O60242 | |
| KTDRFLVNLVKLKHE | 546 | P43652 | |
| TKVLKISDNRFKAHA | 1786 | Q9Y6D6 | |
| RNKISFKFDHLRKEA | 91 | P52907 | |
| DNKLIFHKDRTDLKT | 371 | Q8N556 | |
| KSLKEEFRLHFKNIS | 371 | Q86YB8 | |
| NLTHISAEKRKDKER | 871 | Q14687 | |
| DATLRKKAEKFQAHL | 341 | Q9Y312 | |
| NKSKITIDIHFLERK | 1346 | Q9BXX3 | |
| KARRNTLHKEKDHLV | 456 | Q8N8E3 | |
| VEQRLKLFKLASEKH | 626 | P50416 | |
| ADKLHKFEKELQRIS | 466 | Q8IY63 | |
| LDERDKKKRTALHLA | 76 | Q6NSI1 | |
| SHKHLIELRREFKKN | 41 | O14529 | |
| KLSALLFKHKEQLRA | 2736 | Q12830 | |
| INKLFEKTRKVSAHI | 86 | Q5BKX8 | |
| SASERQIKKAFHKLA | 36 | Q9UBS3 | |
| VFLEHQTKVLKKRHT | 111 | Q02487 | |
| AVRHFLLRKKQEKFT | 3191 | Q8IZT6 | |
| QISRRKHLFSRDKLK | 211 | Q9NRL2 | |
| LVKKDRSASHLDHKR | 631 | Q04656 | |
| ESLKRRSFHIENKLK | 656 | Q96L93 | |
| KVAEKFRAKHNERFI | 1221 | Q9ULI1 | |
| FRRTKQEIKSAHKIA | 736 | Q7Z401 | |
| DDARKSERLHRKKLN | 596 | Q9NTZ6 | |
| RKLAKIKQDTVSHDR | 166 | O75901 | |
| LISREISKFRDTHKK | 276 | P49756 | |
| RERFELLKHQKLKDQ | 466 | Q9NW13 | |
| EKKKLKRHLALFRSE | 406 | Q96P65 | |
| HTKIHLRQKERKSSA | 416 | P11161 | |
| KKILKESRQRHLENF | 416 | Q86VS3 | |
| DRHLHLSSKKKESQL | 146 | O60890 | |
| RVEKLERSLSKLKHQ | 71 | Q08AF8 | |
| KRLKSKDALKRHQEN | 271 | Q9NQX1 | |
| KINHFTRLEDAKKDF | 111 | Q9Y6F1 | |
| TAAELLRHKFFQKAK | 281 | O95747 | |
| RAKAEFHLAELQAKK | 1361 | Q6ZRR7 | |
| TLSERGLLKDFLKKH | 31 | P0DJD9 | |
| KHLFNLKFAAKELSR | 6 | Q7LBR1 | |
| KLRVKNKHVEFFRNL | 386 | O95461 | |
| IERKQKKRHSFLESE | 616 | Q49MG5 | |
| NFLCVHKKLRSKRVA | 246 | P30419 | |
| EINFLCVHKKLRSKR | 246 | O60551 | |
| TKEFVKKIAAENRLH | 196 | O75648 | |
| KKESEFHFSKLKRRQ | 156 | Q8NCR3 | |
| FHFSKLKRRQDLEKK | 161 | Q8NCR3 | |
| ARKLELTKAEKHVHN | 366 | Q92952 | |
| LSFKRKHFLIKLHAN | 231 | Q6ZUT3 | |
| AHKQRLKDLKQREFA | 161 | Q9UKJ3 | |
| RLVNHFVEEFKRKHK | 236 | P0DMV9 | |
| DRHLRKLDQELAKFK | 91 | Q9NXR8 | |
| FSLEEKSKISKNRVH | 111 | Q96BK5 | |
| SKIRQNLKEKHARHI | 441 | Q99550 | |
| LFVKLRKRHLLKDDA | 61 | P16050 | |
| RESHKQSLLKEKKRL | 326 | Q8IUZ0 | |
| DHEDLLKRKRKILSS | 941 | Q5S007 | |
| NHEAFKDELKTFRLK | 546 | P30305 | |
| RTHRFLEKAKALKIS | 1196 | P07942 | |
| VFRQHFLTKKDLIKA | 1421 | P50748 | |
| LTENSFTRKKNLHRK | 356 | Q9UHN1 | |
| ESELRKFLKHHLRGK | 166 | Q15040 | |
| KDVKEAVKHLLNRRF | 301 | Q8NGS9 | |
| FVKRHKLESELIKSA | 371 | Q8IVL5 | |
| KRHREFLTKTAKFKE | 236 | Q5MIZ7 | |
| LSSFLHSEQKKRKLI | 301 | Q86WC4 | |
| AHHALLQKLKEEKSR | 2786 | O95613 | |
| KRVLHRDIKSKNIFL | 121 | P51956 | |
| TLSERGLLKDFLKKH | 31 | P0DJD8 | |
| KTVRHKEAEFLQKLL | 141 | A2A3N6 | |
| KILDRKRHNSISEAK | 1096 | Q01970 | |
| KAKSETFRLLHAKNI | 166 | Q01780 | |
| EKQKKHSFLSQRETL | 361 | Q9ULG6 | |
| LTFRHITKAQEKTRK | 51 | Q9C0G6 | |
| FISRKLLNAKHSEKS | 36 | Q6PH81 | |
| SPDHRQKKHRKLSEL | 151 | Q14241 | |
| HKLLRKIFKANHLED | 436 | Q9NVM4 | |
| AKSHLKDDRSRLVKQ | 1051 | Q0VF96 | |
| EDAKLEKILSKQRFH | 286 | Q8IW35 | |
| KHRHKFSEELLQELK | 26 | A0A1W2PPK0 | |
| SKRFEIKHRLQCKNF | 471 | Q14435 | |
| FFLSKKKTDELRNLH | 96 | P35659 | |
| EEQKRKDLRKSHLVF | 461 | Q8TF46 | |
| KIIAERHFDHLRAKK | 31 | O95999 | |
| LHRKVSSLIEFLKQK | 351 | Q96RY5 | |
| HTNFKKLRLVDIKEF | 286 | Q8WXX0 | |
| RKHLDLKEVAIKQFR | 416 | Q8NHH9 | |
| LREKDLKKLHRAASV | 21 | Q92527 | |
| ALEAEIRTLKHKFKT | 581 | Q2TAC2 | |
| RKKLLHNSEDEQSLK | 1671 | Q9NSI6 | |
| FSEKELAAEKKRILH | 266 | P53004 | |
| IKRFDKLLFVIHKSL | 3201 | Q0VDD8 | |
| DLDLAKKKHASLRQT | 771 | Q8NDI1 | |
| HVFESFLKIIRQKEK | 1291 | Q99698 | |
| VHLRKVKFQAKLEHE | 56 | Q9UPY8 | |
| KESDLRDVKKTQIHF | 131 | Q9NS73 | |
| RLVNHFVEEFKRKHK | 236 | P0DMV8 | |
| SLRFKRIKETKKELH | 1011 | Q5T890 | |
| SRLLHLHFKDDKTKV | 16 | A8MT69 | |
| RARAKEFHKKTLEKL | 2581 | Q9C0D2 | |
| LRKHVEFRKQKDIDN | 56 | O76054 | |
| LRHQKLLEDARKNHK | 236 | Q9C0B2 | |
| RKNHKVAVRFLKASL | 246 | Q9C0B2 | |
| NTKKLSARDHQKLER | 46 | Q13555 | |
| FKRHQRLKKDSTQAE | 401 | Q8NC60 | |
| IKKKSHNLRARLEAF | 86 | Q13474 | |
| QLREKNFDEFSKHLK | 141 | Q15648 | |
| NTKKLSARDHQKLER | 46 | Q13557 | |
| FKHLRHLEILQLSKN | 106 | Q9NT99 | |
| LKKNRRVRESHFLTK | 841 | Q9P2P1 | |
| TLSERGLLKDFLKKH | 31 | P0DJD7 | |
| LRKQLRCDTHKVLKF | 346 | P33402 | |
| KQKHQLKHRELFLSR | 81 | Q9BTC8 | |
| LKQATKDRVSDFHKL | 341 | Q6P4E1 | |
| DILFKAKRKRVFEHH | 36 | Q6P1K8 | |
| NTKKLSARDHQKLER | 46 | Q13554 | |
| SHKEKVRRSLRLKFN | 426 | Q6P4F7 | |
| AHLHFEKLERFQKLK | 171 | Q9C093 | |
| VREFLTALKSHKLTK | 66 | O75575 | |
| LHFQEEKQRLHLKKF | 31 | Q8TBZ9 | |
| KELHEKFDLLKRTHQ | 361 | Q9NVA2 | |
| RHQEKKRKFLESTDS | 251 | Q969G3 | |
| KDIHRSLKDAHVKSR | 161 | Q9ULS5 | |
| RLKELHLEHNQFSKL | 206 | Q86VH5 | |
| SKKRTLKENLSDHLR | 856 | P30414 | |
| TAKELLKHKFILRNA | 276 | Q9Y6E0 | |
| KKSKTLQEFLERIHL | 241 | Q9NSI8 | |
| AKLFSRKESLKQHVS | 771 | P57071 | |
| RNFDLKKHVRKLHDS | 411 | A0PJY2 | |
| DELFQSKLDLRRHKK | 236 | Q9HAZ2 | |
| ESDLSKVRHKLRKFL | 661 | Q6ZUM4 | |
| KEKRTIIHQAIKSLF | 201 | Q96PZ0 | |
| KQLHFFDSRLKDLKL | 351 | Q86UG4 | |
| SNSHDRALVKRKLKE | 371 | Q8IZD0 | |
| KQAFHDSLKKIAFRL | 296 | A6NDL8 | |
| LKLLRTHFKKSLDDG | 476 | Q9Y6Y8 | |
| HDFLQRKSHSRKELK | 291 | Q5H9E4 | |
| KERKVSLFLHVLKTN | 241 | G3V0H7 | |
| TKKLSARDHQKLERE | 46 | Q9UQM7 | |
| LRFINSLKEKKSEEH | 481 | A4IF30 | |
| KCKRLTRFHNQSELK | 166 | Q9BQB4 | |
| FLEKRLHKTHRLKES | 316 | Q9NPQ8 | |
| KKIHEEFSEHALLRK | 676 | Q9Y2L1 | |
| NLEEFASKHKQEIRK | 46 | Q96H20 | |
| SRLLKHERKNISIFK | 306 | P34969 | |
| HERKNISIFKREQKA | 311 | P34969 | |
| FFTRLVRKHDKLKKE | 11 | Q14201 | |
| KHLSDASIKKRQLER | 261 | Q02040 | |
| RKTINDIFKHEKLSR | 766 | Q14865 | |
| SIAHRDFKSKNVLLK | 316 | Q13705 | |
| STVLQKSIDFLRKHK | 71 | O15516 | |
| KSIDFLRKHKEITAQ | 76 | O15516 | |
| DFLEITERAKKAHLK | 136 | Q8WW14 | |
| HLAQLRKKFEEDKQR | 76 | Q9NSQ0 | |
| LQDHEKKLRLVFKSL | 76 | Q6KCM7 | |
| KNKKDSLRHSRFRLD | 201 | P48995 | |
| DKLKRITKSLLEDFH | 356 | Q8WWU5 | |
| KHRESKDNFLKSVLL | 91 | Q5T5D7 | |
| VCESAFNRKDKLKRH | 626 | Q9BYN7 | |
| KAFREKSKLIIHQRI | 521 | P17025 | |
| KVFSHQKRLLEHQKV | 536 | Q6P9A3 | |
| RSFHLLKKNEKLLRE | 1781 | Q6GYQ0 | |
| SLTLRRVFKKEAEHK | 1021 | Q9NZQ8 | |
| FNEHIEALTKKKREH | 946 | O14776 | |
| EALTKKKREHFRQLL | 951 | O14776 | |
| DILFKAKRKRVFEHH | 36 | Q13888 | |
| HQLSKSEEKELRKFR | 806 | Q8IWA0 | |
| HLRKTLKDDLASKAN | 611 | Q5XPI4 | |
| KSQKVFSEKLDHLSR | 806 | Q5XPI4 | |
| HRFEKISNIIKQFKL | 226 | Q7L523 | |
| HLERNRKDKDAKFRL | 101 | P62277 | |
| NLRKKHKRLEAELAA | 1801 | Q13813 | |
| KSRFARLKHQEKFHL | 501 | Q5SVQ8 | |
| KSAHRKLKVSHDNLT | 491 | O15344 | |
| IKSEKLHLKDFRINL | 206 | Q9NW97 | |
| VFLKALQKLKARSFH | 456 | O43548 | |
| LNRHKNIHTVKKLFE | 236 | Q9Y6R6 | |
| LLKHKQIHTRNKAFR | 231 | Q6IQ21 | |
| FLKKSRLNIHQKTHT | 271 | Q9GZX5 | |
| KVFARSENLKIHKRT | 311 | Q15915 | |
| FTADRHKKRKLLENS | 126 | Q9Y6I4 | |
| DEARKKFHQLSLAIK | 111 | Q9BXA7 | |
| LHKELNCKSKRAVRD | 2591 | O43149 | |
| KIFSQKSDLIRHRKT | 416 | Q3MIS6 | |
| EKVFRNNSSLKVHKR | 651 | Q8NB50 | |
| IKDSFQKLILRRHKK | 91 | Q6ZN08 | |
| FKKAASLEQHLRLHR | 341 | Q8TF50 | |
| RLQFLTSKEKAEHKA | 476 | Q8ND82 | |
| SLELHVKRKHTKEFE | 1031 | Q9C0G0 | |
| DLNLREKKTKDHFLI | 2101 | O15050 | |
| EKSLHEKLKQDKRFS | 496 | Q15063 | |
| KISLLHSSKEKLRRE | 201 | Q9NX45 | |
| KAFRQKTALTLHEKT | 331 | Q96SR6 | |
| AFFKKSELIRHQKIH | 401 | Q86T29 | |
| RLTKEKLDFHEAQQK | 81 | Q14966 | |
| HLFNIISRKKEALKD | 111 | O94782 | |
| VESKDRKANAHFILK | 1076 | O95071 | |
| LSEKFGKNLNKDHLR | 841 | Q9HCX4 | |
| HAHKQRLKELKQREF | 81 | Q7Z570 | |
| AFLKKSQLTEHKRIH | 186 | Q9BS31 | |
| LKAELSTDKDFRKHR | 166 | Q8TCI5 | |
| ALRKKVQFAKDEDLH | 791 | Q5R3F8 | |
| HLNDLKKENFSLKLR | 11 | Q5VU43 |